Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study
Authors:
- Jin Eun ChoiJCJin Eun Choi
- Sun Ha ParkSPSun Ha Park
- Kyung Mee KimKKKyung Mee Kim
- Won Kee LeeWLWon Kee Lee
- Sin KamSKSin Kam
- Sung Ick ChaSCSung Ick Cha
- Chang Ho KimCKChang Ho Kim
- Young Mo KangYKYoung Mo Kang
- Young-Chul KimYKYoung-Chul Kim
- Sung Beom HanSHSung Beom Han
- Tae Hoon JungTJTae Hoon Jung
- Jae Yong ParkJPJae Yong Park
Open Access
- 24 October 2007
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 199
Abstract
Background: Polymorphisms in Epidermal Growth Factor Receptor (EGFR) gene may influence EGFR production and/or activity, thereby modulating susceptibility to lung cancer. To test this hypothesis, we investigated the association between polymorphisms in theEGFRgene and the risk of lung cancer in a Korean population.Methods: We first examined the frequencies of 39 candidate polymorphisms in theEGFRgene in 27 healthy Korean individuals. After then, we genotyped five polymorphisms (127378C>T, 142285G>A, 162093G>A, 181946C>T and 187114T>C) that have variant allele frequencies greater than 10%, in 582 lung cancer patients and in 582 healthy controls.Results: Of the 5 polymorphisms, the 181946C>T genotype distribution was significantly different between the cases and controls (P= 0.04). Compared with the 181946 CC + CT genotype, the 181946 TT genotype was associated with a significantly decreased risk of lung cancer (adjusted OR = 0.63, 95% CI = 0.45–0.88,P= 0.007). When the analyses were stratified by smoking status, the protective effect of the TT genotype was statistically significant in ever-smokers (adjusted OR = 0.59, 95% CI = 0.41–0.86,P= 0.007), but not in never-smokers (adjusted OR = 0.89, 95% CI = 0.45–1.75,P= 0.73;P= 0.08, test for homogeneity). Consistent with the results of the genotyping analysis, the CGGCT haplotype with the 181946C allele was associated with a significantly increased risk of lung cancer compared to the CGGTT haplotype carrying the 181946T allele (adjusted OR = 1.50, 95% CI = 1.09–2.07,P= 0.012 and Bonferroni correctedP-value = 0.048).Conclusion: These results suggest that theEGFRpolymorphisms, particularly the 181945C>T polymorphism, could be used as markers for the genetic susceptibility to lung cancer.Keywords
This publication has 32 references indexed in Scilit:
- Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean populationLung Cancer, 2006
- Methyl-CpG Binding Domain 1Gene Polymorphisms and Risk of Primary Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-?? (TGFA) gene and risk of oral cancer in Puerto RicoPharmacogenetics and Genomics, 2005
- T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomasFertility and Sterility, 2005
- An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor InhibitorsCancer Research, 2004
- Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasiaSeminars in Oncology, 2002
- Gene–environment interaction and aetiology of cancer: what does it mean and how can we measure it?Carcinogenesis, 2002
- Effectiveness of computational methods in haplotype predictionHuman Genetics, 2001
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- A Measure of Phase Ambiguity in Pairs of SNPs in the Presence ofLinkage Disequi libriumHuman Heredity, 2000